Bahrain Kicks Off Medical Normalization with ’Israeli’ Entity

By Staff, Agencies

In the course of widening the fields of normalization with the Zionist occupation entity, Bahrain’s National Health Regulatory Authority [NHRA] authorized a  clinical study to evaluate the use of 'Israeli'-made Enovid nasal spray to treat individuals with COVID-19.

The authorisation follows a medical study submitted by the relevant authorities at the Ministry of Health, which indicates their support for a clinical trial to take place in the Kingdom of Bahrain. Enovid, which is produced in the 'Israeli'-occupied Palestinian territories, will be tested on volunteers who have already been diagnosed with COVID-19 and who are suffering from mild symptoms.

The NHRA noted that upon completion of the trial and further analysis of medical data, the spray will be approved for use as prevention and treatment for mild COVID-19 cases and may be sold in pharmacies without prescription.

Bahrain started unashamed diplomatic ties with the Zionist regime last fall in a US-brokered deal under the Trump administration and following the United Arab Emirates' similar treacherous step.

The pacts, rejected by the Palestinians as a betrayal of their cause, signaled an increasingly explicit alliance between Gulf Arab states and the Zionist regime.